American biotechnology company Moderna’s experimental coronavirus vaccine has shown to be safe and effective at provoking immune responses in an early-stage study.
COVID-19 <%ec%98%81%ec%96%b4%eb%89%b4%ec%8a%a4 class="post-title"> Celltrion Revealed Results from Phase 1 Trial of COVID-19 Monoclonal Antibody Therapy %ec%98%81%ec%96%b4%eb%89%b4%ec%8a%a4>